Search Results

1 - 3 of 3 items :

  • Clinical Medicine, other x
  • History and Ethics of Medicine x
Clear All

the pathophysiology and biomarker discovery. Expert Rev Proteomics. 2005; 2(3): 349-366. 5. Andersen S, Mischak H, Zürbig P et al. Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria. BMC Nephrol. 2010; 11(1): 29- 6. Stalmach A, Albalat A, Mullen W, and Mischak H. Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications. Electrophoresis. 2013; 34(11): 1452-1464. 7. Pontillo C, Filip S, Borras DM et al. CE-MS-based proteomics in biomarker

Proteome Res. 2009; 8(7): 3752-3759. 35. Stahl DC, Swiderek KM, Davis MT, Lee TD. Datacontrolled automation of liquid chromatography/tandem mass spectrometry analysis of peptide mixtures. J Am Soc Mass Spectrom. 1996; 7(6): 532-540. 36. Silva JC, Gorenstein MV, Li GZ, Vissers JP, Geromanos SJ. Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol Cell Proteomics. 2006; 5(1): 144-156. 37. Liu Y, Chen J, Sethi A, et al. Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase

(2): 259–67. 101. Argiles A, Siwy J, Duranton F et al. CKD273, a New Proteomics Classifier Assessing CKD and Its Prognosis. PLoS One. 2013; 8(5): e62837 102. Pontillo C, Jacobs L, Staessen JA et al. A Urinary proteome-based Classifier for the early Detection of Decline in Glomerular Filtration. Nephrol Dial Transplant. 2017; 32(9): 1510–16. 103. Kramer H, Boucher RE, Leehey D et al. Increasing mortality in adults with diabetes and low estimated glomerular filtration rate in the absence of albuminuria. Diabetes Care. 2018; 41(4): 775–81. 104. Zürbig P, Mischak H, Menne J